Dystrophin: Gene, Protein and Cell Biology

Portada
Susan C.. Brown, Susan C. Brown, Susan S. Brown, Jack A. Lucy
Cambridge University Press, 13 may. 1997 - 338 páginas
This book is concerned with advances in research on dystrophin, and how its absence gives rise to muscular dystrophy. It is the first book to address relationships between the molecular structure and function of dystrophin since the structure of the gene for this protein was elucidated in 1988. The volume covers recent advances in knowledge on the structure of both the dystrophin gene and its associated promoters, and on the protein itself. Functional interactions of dystrophin and its related proteins in the environment of the plasma membrane are a central feature of the book. Other aspects considered are the expression of the dystrophin complex in muscle, in the brain, and at the neuromuscular junction. The book concludes with discussions of muscle regeneration, gene therapy of Duchenne muscular dystrophy, and cellular approaches to the therapy of the disease.

Dentro del libro

Comentarios de usuarios - Escribir una reseña

No hemos encontrado ninguna reseña en los sitios habituales.

Índice

Dystrophin domains
10
Exceptions and phenotypegenotype correlations
16
2
22
Dystrophin utrophin and their associated proteins
56
Localization of dystrophin in skeletal cardiac and smooth
79
Expression of the dystrophin complex in the brain
105
retardation
121
42
132
48
177
51
194
a clinical
201
Muscle regeneration
233
Gene therapy of Duchenne muscular dystrophy
274
Models of dystrophinopathy pathological mechanisms
310
Stages of disease in dystrophinopathies
316
Index
333

The dystrophin family agrin and construction of
139
Functions of dystrophin
163

Términos y frases comunes

Pasajes populares

Página 302 - Burns, JC, Friedmann, T., Driever, W., Burrascano, M., and Yee, JK (1993) Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells. Proc. Natl. Acad. Sci. USA 90, 8033-8037.
Página 23 - M et al (1989) The molecular basis for Duchenne versus Becker muscular dystrophy: correlation of severity with type of deletion. Am J Hum Genet 45 : 498-506 69.
Página 199 - JS (1995) Mutations in the proteolytic enzyme calpain 3 cause limb-girdle muscular dystrophy type 2A. Cell 81, 27-40.
Página 309 - Recombinant IL-12 prevents formation of blocking IgA antibodies to recombinant adenovirus and allows repeated gene therapy to mouse lung. Nat. Med. 1, 890-893.
Página 193 - Stimulation of collagen gene expression by ascorbic acid in cultured human fibroblasts. A role for lipid peroxidation.
Página 26 - Towbin JA, Hejtmancik JF, Brink P, et al. X-linked dilated cardiomyopathy: molecular genetic evidence of linkage to the Duchenne muscular dystrophy (dystrophin) gene at the Xp21 locus. Circulation 1993:87:1854-1865.
Página 194 - Campbell, KP (1993). A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin. J. Cell Biol.
Página 104 - RG (1988). The Duchenne muscular dystrophy gene product is localized in sarcolemma of human skeletal muscle. Nature 333, 466-469.
Página 72 - DR (1992). Construction of a 2.6-Mb contig in yeast artificial chromosomes spanning the human dystrophin gene using an STS-based approach. Genomics 12, 474-484.
Página 224 - Vlodavsky I. Basic fibroblast growth factor binds to subendothelial extracellular matrix and is released by heparitinase and heparin-like molecules. Biochemistry 1989: 28:1737-1743.

Información bibliográfica